On Tuesday, the Biden administration announced that it will be sending a stockpile of approximately 296,000 Monkeypox vaccines to all States in order to prevent any further spread of the disease.
With 306 new cases sprouting up across the country the government will allocate 56,000 doses immediately, and 1.6 million doses will be made available over the coming months.
The Centers for Disease Control and Prevention is recommending that people who have had confirmed or presumed monkeypox exposures get vaccinated against the virus. Vaccination should occur within two weeks of exposure to the virus, but the sooner the better, according to the CDC.
The Jynneos vaccine that is being allocated by the government is a two-dose vaccine approved by the Food and Drug Administration for adults ages 18 and older who are at high risk of exposure to smallpox or monkeypox. HHS is prioritizing the allocation of Jynneos doses to communities with the highest number of monkeypox cases because supply is still limited.
Local health departments can also request shipments of the older generation smallpox vaccine ACAM2000, which the U.S. has in much greater supply. However, the vaccine can have serious side effects and is not recommended for everyone.
Although the Monkeypox virus is endemic in parts of Africa, the current outbreak has hit countries where the virus does not usually spread, sparking concern that it could become more widespread.